BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17037285)

  • 1. [Fibrinogen--acute phase protein as a marker of immunological process as atherosclerosis].
    Rajtari R; Kloch M; Kiec-Wilk B; Kolasińska-Kloch W
    Folia Med Cracov; 2005; 46(1-2):21-32. PubMed ID: 17037285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinogen: factor and marker of cardiovascular risk].
    Drouet L; Bal Dit Sollier C
    J Mal Vasc; 2002 Jun; 27(3):143-56. PubMed ID: 12232531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease.
    Kryczka KE; Kruk M; Demkow M; Lubiszewska B
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):767-72. PubMed ID: 17479867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: a longitudinal study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Ann Epidemiol; 2007 Jan; 17(1):57-63. PubMed ID: 17178329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers and conventional atherosclerotic risk factors in acute ischemic stroke: comparative study between vascular disease subtypes.
    Suwanwela NC; Chutinet A; Phanthumchinda K
    J Med Assoc Thai; 2006 Dec; 89(12):2021-7. PubMed ID: 17214052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
    Coutinho Tde A; Turner ST; Peyser PA; Bielak LF; Sheedy PF; Kullo IJ
    Am J Hypertens; 2007 Jan; 20(1):83-9. PubMed ID: 17198917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of biochemical risk factors and markers for the risk of atherosclerosis].
    Montagnana M; Lippi G; Salvagno GL; Franchini M; Targher G; Guidi GC
    Recenti Prog Med; 2008 Apr; 99(4):215-22. PubMed ID: 18595637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and long-term risk markers.
    Levinson SS
    Clin Lab Med; 2006 Sep; 26(3):553-70, v. PubMed ID: 16938584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation biomarkers and near-term death in older men.
    Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
    Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibrinogen and fibrinolysis in peripheral arterial disease.
    Paraskevas KI; Baker DM; Vrentzos GE; Mikhailidis DP
    Thromb Res; 2008; 122(1):1-12. PubMed ID: 17669476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.
    Wu TJ; Ou HY; Chou CW; Hsiao SH; Lin CY; Kao PC
    Ann Clin Lab Sci; 2007; 37(2):158-66. PubMed ID: 17522372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.
    Ranjit N; Diez-Roux AV; Shea S; Cushman M; Seeman T; Jackson SA; Ni H
    Arch Intern Med; 2007 Jan; 167(2):174-81. PubMed ID: 17242319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammatory autoimmune disorders and atherosclerosis.
    Abou-Raya S; Abou-Raya A; Naim A; Abuelkheir H
    Ann N Y Acad Sci; 2007 Jun; 1107():56-67. PubMed ID: 17804533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of educational level to inflammation-sensitive biomarker level.
    Steinvil A; Shirom A; Melamed S; Toker S; Justo D; Saar N; Shapira I; Berliner S; Rogowski O
    Am J Cardiol; 2008 Oct; 102(8):1034-9. PubMed ID: 18929705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans.
    Liu SW; Qiao SB; Yuan JS; Liu DQ
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):202-7. PubMed ID: 19178507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between resting heart rate and atherosclerosis risk factors.
    Piwońska A; Piotrowski W; Broda G; Drygas W; Głuszek J; Zdrojewski T; Kozakiewicz K; Stepaniak U; Bandosz P
    Kardiol Pol; 2008 Oct; 66(10):1069-75; discussion 1076-8. PubMed ID: 19006028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study.
    Donahue RP; Rejman K; Rafalson LB; Dmochowski J; Stranges S; Trevisan M
    Diabetes Care; 2007 Feb; 30(2):354-9. PubMed ID: 17259507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.